Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 389

1.

Estrogen receptor-beta as a potential target for colon cancer prevention: chemoprevention of azoxymethane-induced colon carcinogenesis by raloxifene in F344 rats.

Janakiram NB, Steele VE, Rao CV.

Cancer Prev Res (Phila). 2009 Jan;2(1):52-9. doi: 10.1158/1940-6207.CAPR-08-0140.

3.

Chemoprevention of azoxymethane-induced rat colon carcinogenesis by a xanthine oxidase inhibitor, 1'-acetoxychavicol acetate.

Tanaka T, Kawabata K, Kakumoto M, Makita H, Matsunaga K, Mori H, Satoh K, Hara A, Murakami A, Koshimizu K, Ohigashi H.

Jpn J Cancer Res. 1997 Sep;88(9):821-30.

PMID:
9369929
4.

Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets.

Rao CV, Reddy BS, Steele VE, Wang CX, Liu X, Ouyang N, Patlolla JM, Simi B, Kopelovich L, Rigas B.

Mol Cancer Ther. 2006 Jun;5(6):1530-8.

6.

Beta-ionone inhibits colonic aberrant crypt foci formation in rats, suppresses cell growth, and induces retinoid X receptor-alpha in human colon cancer cells.

Janakiram NB, Cooma I, Mohammed A, Steele VE, Rao CV.

Mol Cancer Ther. 2008 Jan;7(1):181-90. doi: 10.1158/1535-7163.MCT-07-0529.

7.

Inhibitory effect of caffeic acid esters on azoxymethane-induced biochemical changes and aberrant crypt foci formation in rat colon.

Rao CV, Desai D, Simi B, Kulkarni N, Amin S, Reddy BS.

Cancer Res. 1993 Sep 15;53(18):4182-8.

10.
11.

Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.

Kishimoto Y, Morisawa T, Hosoda A, Shiota G, Kawasaki H, Hasegawa J.

J Exp Clin Cancer Res. 2002 Jun;21(2):203-11.

PMID:
12148579
12.

Modulation of experimental colon tumorigenesis by types and amounts of dietary fatty acids.

Rao CV, Hirose Y, Indranie C, Reddy BS.

Cancer Res. 2001 Mar 1;61(5):1927-33.

13.

Evaluation of benzyl selenocyanate glutathione conjugate for potential chemopreventive properties in colon carcinogenesis.

Kawamori T, El-Bayoumy K, Ji BY, Rodriguez JG, Rao CV, Reddy BS.

Int J Oncol. 1998 Jul;13(1):29-34.

PMID:
9625800
14.
15.

Chemopreventive effect of 2-(allylthio)pyrazine (2-AP) on rat colon carcinogenesis induced by azoxymethane (AOM).

Kim DJ, Kang JS, Ahn B, Kim KS, Park KH, Choi KS, Surh YJ, Kim ND.

Cancer Lett. 2001 May 26;166(2):125-33.

PMID:
11311484
17.

Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor.

Rao CV, Kawamori T, Hamid R, Reddy BS.

Carcinogenesis. 1999 Apr;20(4):641-4.

PMID:
10223193
18.

Chemoprevention of colon cancer by a glutathione conjugate of 1,4-phenylenebis(methylene)selenocyanate, a novel organoselenium compound with low toxicity.

Rao CV, Wang CQ, Simi B, Rodriguez JG, Cooma I, El-Bayoumy K, Reddy BS.

Cancer Res. 2001 May 1;61(9):3647-52.

19.

Soy isoflavones modulate azoxymethane-induced rat colon carcinogenesis exposed pre- and postnatally and inhibit growth of DLD-1 human colon adenocarcinoma cells by increasing the expression of estrogen receptor-beta.

Raju J, Bielecki A, Caldwell D, Lok E, Taylor M, Kapal K, Curran I, Cooke GM, Bird RP, Mehta R.

J Nutr. 2009 Mar;139(3):474-81. doi: 10.3945/jn.108.099200. Epub 2009 Jan 13.

20.

Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.

Wali RK, Khare S, Tretiakova M, Cohen G, Nguyen L, Hart J, Wang J, Wen M, Ramaswamy A, Joseph L, Sitrin M, Brasitus T, Bissonnette M.

Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1653-62.

Supplemental Content

Support Center